Attachment
Reading Room Production, p.191 · reading_room:exh:00059
Page text: p.191 · original PDF
- Date
- — (unknown precision)
- Type
- attachment · document
VIL researchers traveled to Wuhan, nor
wa
DRAFT, PRE-DECISIONAL
1 CoV could replicate in Egyptian fruit bats. No RML researchers traveled to Wuhan, nor
were any viruses brought back or shipped to RML.
4. NIH obtained Egyptian fruit bats from a zoo in Maryland, transported them across state lines
to Montana, and experimented on them with a coronavirus.
Facts: The work done at RML in 2016 used Egyptian fruit bats obtained by standard
procurement and procedures and delivered to RML via a USDA approved animal
provider with the appropriate permits in place. These bats were infected with WIV-1 to
determine its ability to replicate in bats; it was found to be poorly able to do so in this
experiment.
5. RML in Montana has a history of infected animals escaping, unauthorized people getting into
the lab, and bioweapons development.
Facts: This work was done in an RML facility first used in 20098. The facility contains
high containment laboratories, employs the highest possible safety standards to protect
scientists and the surrounding community. RML has a longstanding history of excellent
biosafety and biocontainment practices with minimal incidents that have posed negligible
to no risk to personnel or the community. There have been zero incidents of unauthorized
individuals accessing any high or maximum containment labs. RML does not conduct
research on bioweapons development. The referenced report of an infected animal escape
was taken out of context from a mandatory regulatory report to the Federal Select Agent
Program wherein which a rodent escaped from its home cage but remained contained in
the BSL-4 lab and was subsequently recaptured. The animal remained within the BSL-4
primary containment barrier and never escaped the laboratory.
6. NIH is spending $125 million of COVID relief funds to expand its bat laboratories.
Facts: The CARES Act provided funding specifically for the construction of NIAID
vaccine and infectious disease research facilities, including the BSL-2 animal facility that
will allow RML scientists to better respond to new and emerging pandemic threats. The
facility is designed to enable research with a number of different types of animal models,
not just bats. The animals housed at the BSL-2 facility could be subsequently used in
experiments requiring BSL-3 or BSL-4 containment, as appropriate. These BSL-3 and -4
facilities are already existing at RML.
UK Daily Mail Article Allegations
1. NIH infected 12 Egyptian fruit bats with a SARS-like virus called WIV-1 at RML in
Montana in 2018.
Facts: At RML, experimental studies to help understand if WIV-1 CoV could replicate in